Clinical trial
Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer
NCT01341886 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer
- Lead sponsor
- Mashhad University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- April 30, 2011
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant neoplasm of thyroid stage i, malignant neoplasm of thyroid stage ii